mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.3 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.05 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0008 |